内透析高血压患者的透析和短期血压变化:一个随机交叉研究
Fotini Iatridi1, Robert Ekart2, Efstathios Xagas3
1First Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. fotini.iatridi@gmail.com.
Journal of human hypertension
|August 24, 2024
概括
在血液透析中低透析盐度不会显著改变血压变化 (BPV) 在患者内透析性高血压 (IDH). 为了在这个高风险群体中降低BP和BPV的有效干预措施,需要进一步的研究.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心血管医学 心血管医学
- 临床高血压是指临床高血压.
背景情况:
- 血压变化 (BPV) 的增加与血液透析患者心血管风险的增加有关.
- 内日分析性高血压 (IDH) 与没有IDH的血液透析患者相比,进一步增加了心血管风险.
- 在IDH患者中,非药物干预对BPV的影响尚不清楚.
研究的目的:
- 评估低 (137mEq/L) 与标准 (140mEq/L) 透析盐度对IDH患者短期BPV的影响.
- 为了确定改变透析是否会影响血压和血液透析期间的血压变化.
主要方法:
- 一项随机交叉研究,涉及29名IDH患者.
- 患者接受了4次低透剂和4次标准透剂治疗.
- 进行了48小时的门诊血压监测,并计算了各种BPV指数.
主要成果:
- 平均48小时血压与低透析 (5.3/2.6 mmHg低,p<0.01) 显著降低.
- 在两种透析盐度之间的任何48小时缩BPV指数中没有观察到显著差异.
- 透析BPV指数在数值上较低,但在低透析的情况下没有统计学意义.
结论:
- 低透析盐度不会显著影响血压变化在患者内透析高血压.
- 虽然低透析降低了整体血压,但它没有影响高风险人群中的BPV.
- 需要采取替代干预措施,以有效地降低IDH患者的血压和BPV.
相关概念视频
01:16Antihypertensive Drugs: Action of Diuretics
635
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
635
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
477
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
477
01:18Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
01:22Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
01:25Antihypertensive Drugs: Direct Renin Inhibitors
512
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
512
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
522
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
522